Works matching IS 03407004 AND DT 2004 AND VI 53 AND IP 4

Results: 10

Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 331, doi. 10.1007/s00262-003-0441-4

By:

Ullenhag, Gustav J.;
Fagerberg, Jan;
Strigård, Karin;
Frödin, Jan-Erik;
Mellstedt, Håkan

Publication type:

Article

Clinical applications of dendritic cell vaccination in the treatment of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 275, doi. 10.1007/s00262-003-0432-5

By:

Cranmer, Lee D.;
Trevor, Katrina T.;
Hersh, Evan M.

Publication type:

Article

Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 358, doi. 10.1007/s00262-003-0440-5

By:

Weiss, Lola;
Or, Reuven;
Slavin, Shimon;
Naparstek, Ella;
Reich, Shoshana;
Abdul-Hai, Ali

Publication type:

Article

Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 363, doi. 10.1007/s00262-003-0449-9

By:

Lasek, Witold;
Basak, Grzegorz;
Şwitaj, Tomasz;
Jakubowska, Anna B.;
Wysocki, Piotr J.;
Mackiewicz, Andrzej;
Drela, Nadzieja;
Jalili, Ahmad;
Kamiński, Rafal;
Kozar, Katarzyna;
Jakóbisiak, Marek

Publication type:

Article

A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 345, doi. 10.1007/s00262-003-0450-3

By:

Card, Kimberlyn F.;
Price-Schiavi, Shari A.;
Liu, Bai;
Thomson, Elizabeth;
Nieves, Esperanza;
Belmont, Heather;
Builes, Janette;
Jiao, Jin-an;
Hernandez, Javier;
Weidanz, Jon;
Sherman, Linda;
Francis, John L.;
Amirkhosravi, Ali;
Wong, Hing C.

Publication type:

Article

Her-2/neu altered peptide ligand–induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 307, doi. 10.1007/s00262-003-0439-y

By:

Dionne, Sara O.;
Myers, Cheryl E.;
Smith, Margaret H.;
Lake, Douglas F.

Publication type:

Article

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 323, doi. 10.1007/s00262-003-0452-1

By:

Todryk, Stephen M.;
Eaton, Jonathan;
Birchall, Lindsay;
Greenhalgh, Rebecca;
Soars, Diane;
Dalgleish, Angus G.;
Melcher, Alan A.;
Pandha, Hardev S.

Publication type:

Article

Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I–mediated antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 315, doi. 10.1007/s00262-003-0448-x

By:

Kwang-Woon Kim;
Sun-Hee Kim;
Jung-Hee Jang;
Eun-Yup Lee;
Soon-Won Park;
Jee-Hyun Um;
Yun-Jung Lee;
Chang-Hun Lee;
Sik Yoon;
Su-Yeong Seo;
Min-Ho Jeong;
Seong-Tae Lee;
Byung-Seon Chung;
Chi-Dug Kang

Publication type:

Article

Acknowledgement to Reviewers in 2003.

Published in:: Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 373, doi. 10.1007/s00262-004-0510-3
Publication type:: Article

Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes.

Published in:

Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 338, doi. 10.1007/s00262-003-0447-y

By:

Higgins, Robert J.;
McKisic, Maureen;
Dickinson, Peter J.;
Jimenez, Daniel F.;
Dow, Steven W.;
Tripp, Linda D.;
LeCouteur, Richard A.

Publication type:

Article